Basic research leads to drug candidates for fatal lung disease

During the 1990s, medicinal chemist Anders Hallberg was working in his lab at the Department of Medicinal Chemistry. He was exploring a hormonal system in the body that regulates blood pressure, among other things, by designing different molecules. Thirty years later, one of these molecules has been developed into a drug candidate to treat a severe and incurable disease, idiopathic pulmonary fibrosis, and is now being tested on patients in multiple countries.

This post was originally published on this site